Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Simpson
Jerry Yik

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Bioorganic & Medicinal Chemistry Letters|September 21, 2017
Discovery and optimization of oxadiazole-based FLAP inhibitorsAlessandra Bartolozzi, Asitha Abeywardane, Todd Bosanac, et al.
Open Forum Infectious Diseases|November 2, 2022
Demographics and Outcomes of Initial Phase of COVID-19 Medicines Delivery Units Across 4 UK Centers During Peak B1.1.529 Omicron Epidemic: A Service EvaluationMichael Brown, Jasjot Saund, Azka Qureshi, et al.
Research in Social & Administrative Pharmacy : RSAP|December 21, 2025
Methods used to identify and classify medication-related admissions and readmissions to hospitals: A systematic reviewLinda Krogh, Stephen Carter, Shania Liu, et al.
BMJ Open|June 18, 2025
Timely post-discharge medication reviews to Improve Continuity-the Transitions Of Care stewardship (TIC TOC) study in rural and regional Australia: a parallel-group randomised controlled trial study protocolJonathan Penm, Kingston Yeung, Rebekah Jane Moles, et al.
Clinical and Translational Science|May 17, 2026
Medication Management Strategies at Hospital Admission: A Systematic Review and Meta-AnalysisTara Emadi, Chin Hang Yiu, Shania Liu, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 8, 2021
The potent and selective RIPK2 inhibitor BI 706039 improves intestinal inflammation in the TRUC mouse model of inflammatory bowel diseaseJoerg Ermann, Mederbek Matmusaev, Emma K Haley, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Bioorganic & Medicinal Chemistry Letters|September 21, 2017
Discovery and optimization of oxadiazole-based FLAP inhibitorsAlessandra Bartolozzi, Asitha Abeywardane, Todd Bosanac, et al.
Open Forum Infectious Diseases|November 2, 2022
Demographics and Outcomes of Initial Phase of COVID-19 Medicines Delivery Units Across 4 UK Centers During Peak B1.1.529 Omicron Epidemic: A Service EvaluationMichael Brown, Jasjot Saund, Azka Qureshi, et al.
Research in Social & Administrative Pharmacy : RSAP|December 21, 2025
Methods used to identify and classify medication-related admissions and readmissions to hospitals: A systematic reviewLinda Krogh, Stephen Carter, Shania Liu, et al.
BMJ Open|June 18, 2025
Timely post-discharge medication reviews to Improve Continuity-the Transitions Of Care stewardship (TIC TOC) study in rural and regional Australia: a parallel-group randomised controlled trial study protocolJonathan Penm, Kingston Yeung, Rebekah Jane Moles, et al.
Clinical and Translational Science|May 17, 2026
Medication Management Strategies at Hospital Admission: A Systematic Review and Meta-AnalysisTara Emadi, Chin Hang Yiu, Shania Liu, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 8, 2021
The potent and selective RIPK2 inhibitor BI 706039 improves intestinal inflammation in the TRUC mouse model of inflammatory bowel diseaseJoerg Ermann, Mederbek Matmusaev, Emma K Haley, et al.
Pageof 2